Engflag

Piriton-CS

Quick links to important sections

Piriton-CS

Piriton-CS_EN

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Piriton-CS

Property Description
Active ingredient Chlorpheniramine Maleate, Dextromethorphan Hydrobromide
Form Oral Liquid (Syrup)
Pharmacological class Antihistamine and Antitussive
General purpose Symptomatic relief of cold/allergy symptoms
Origin Synthetic Combination Product

The medication known as Piriton-CS is classified as a synthetic combination drug formulated as an oral liquid (syrup) for the systemic relief of upper respiratory tract symptoms often associated with both the common cold and seasonal allergies. This preparation is a strategic combination designed to manage multiple points of irritation simultaneously, providing a focused approach to symptom control. The syrup form is often used for patients who may have difficulty swallowing solid oral forms.

Composition and Pharmacological Classification

Piriton-CS utilizes two primary active ingredients: Chlorpheniramine Maleate and Dextromethorphan Hydrobromide. Chlorpheniramine Maleate is a first-generation antihistamine that acts as an H1-receptor antagonist, targeting the body's allergic response. This antihistamine is clinically recognized for its efficacy in reducing acute hypersensitivity reactions. The Dextromethorphan component, classified as a central-acting antitussive agent (cough suppressant), is verified to work on the cough center in the brain. A key factor is that Dextromethorphan is structurally non-narcotic, positioning it distinctly from opiate-derived alternatives for cough relief.

General Purpose of the Combination Drug

The general purpose of this combination drug is to provide efficient symptomatic management by simultaneously addressing both the allergic manifestations and the involuntary cough reflex. The Chlorpheniramine Maleate component reduces irritations like sneezing, runny nose, and watery eyes. Concurrently, the Dextromethorphan Hydrobromide component provides effective suppression of the cough reflex. For example, Piriton-CS is typically utilized when an individual is experiencing the dual burden of a persistent cough combined with concurrent allergy-related rhinorrhoea, offering comprehensive relief from both key symptoms. This integrated action facilitates the treatment of multi-symptom cold conditions.

Regulatory References

  1. NIH: Dextromethorphan StatPearls

What side effects are possible with Piriton-CS?

Possible Side Effects and Safety Information

The official safety profile of Piriton-CS, a combination of an antihistamine (Chlorpheniramine Maleate) and an antitussive (Dextromethorphan Hydrobromide), is defined by regulatory documents that classify potential adverse reactions by frequency and affected body system.

Adverse Reaction Classification

Side effects are primarily categorized by their impact on the Nervous System and via anticholinergic activity, as documented in government labeling.

Classification Examples of Documented Adverse Reactions
Common Drowsiness, Sedation, Dizziness, Dry mouth, Impaired coordination
Uncommon/Rare Nausea, Vomiting, Constipation, Urinary retention, Blurred vision, Palpitations

Serious adverse reactions, though rare, are identified in official labeling and include Hypersensitivity Reactions (e.g., anaphylaxis, angioedema) and specific Blood Dyscrasias (e.g., agranulocytosis) associated with the antihistamine component.

Safety Considerations for Specific Populations

Regulatory documents emphasize specific safety patterns for certain groups. Older adults may have an increased susceptibility to sedation, dizziness, and anticholinergic effects like confusion or urinary retention. In children, a paradoxical reaction of excitability or nervousness is a noted possibility instead of expected drowsiness. Furthermore, caution is documented for use in individuals with hepatic impairment due to the metabolic pathways of the active components.

Regulatory Restrictions and Safety Patterns

Safety limitations include restrictions for use in individuals with conditions highly susceptible to anticholinergic effects, such as narrow-angle glaucoma and pre-existing urinary retention. Regarding timing, drowsiness and sedation are documented in official safety texts as being more likely to appear at the beginning of treatment as the body adjusts to the medicine.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents regarding Piriton-CS overdose primarily focus on the documented manifestations of toxicity and the required emergency actions. Manifestations may include a wide spectrum of Central Nervous System (CNS) effects, ranging from profound drowsiness, ataxia, and coma to agitation, hallucinations, and convulsions. Other reported clinical signs are Tachycardia, respiratory depression, and anticholinergic effects such as dilated pupils and dry mouth.

Overdose exposure carries a risk of life-threatening outcomes, including respiratory compromise, severe cardiac arrhythmias, and cardiovascular collapse. Urgent medical intervention is explicitly required for any suspected overdose; contact emergency services immediately, particularly if symptoms such as seizures, trouble breathing, or loss of consciousness occur.

Management is strictly symptomatic and supportive. While no specific antidote is known for the Chlorpheniramine component, specialized treatment protocols, such as the use of Activated Charcoal and Continuous Cardiac Monitoring (ECG), are documented in the official labeling. Furthermore, official labeling notes an increased susceptibility to severe effects in pediatric and elderly populations, including a higher risk of CNS excitation and convulsions in children.

Therapeutic Uses of Piriton-CS

What Piriton-CS Treats: Main Uses and Benefits

Dual Relief for Acute Cold and Allergy Symptoms

This syrup is commonly used across conditions characterized by periods of heightened symptoms related to the common cold and upper respiratory allergies. It helps address symptom clusters that may become intense, providing supportive therapeutic benefit against acute manifestations such as frequent sneezing, bothersome runny nose, and watery, itchy eyes that create noticeable physiological strain.

Piriton-CS is generally applied when supportive symptom management is appropriate for conditions that involve a dry, non-productive cough, and symptoms related to irritative states in the throat. The medication is used for managing the involuntary cough reflex, which, when persistent, can interfere with daily functioning. The overall therapeutic benefit supports general well-being during symptomatic phases.

Quick Fact: Relief for Cough and Allergy Discomfort

Piriton-CS is considered relevant for easing the symptomatic discomfort of upper respiratory tract allergies and the common cold in situations where a dry cough is present. The symptoms it may assist with managing include sneezing, runny nose, itchy eyes, and the frequent cough reflex. The preparation may help improve day-to-day comfort during symptomatic periods.

Regulatory References

  1. NIH DailyMed official labeling

Eligibility and Restrictions for Use

This section details the official population eligibility and non-eligibility for Piriton-CS (Chlorpheniramine Maleate and Dextromethorphan Hydrobromide), as established by governmental regulatory authorities.

Contraindicated and Restricted Use

Classification Population or Condition
Absolute Contraindication Individuals taking a Monoamine Oxidase Inhibitor (MAOI), or those who have stopped MAOI therapy within the last 14 days.
Prohibited Age Group Children under 6 years of age are explicitly prohibited from using this medicine.
Conditional Use Required Patients with Glaucoma, prostatic hypertrophy (enlarged prostate) causing difficulty urinating, severe hypertension, or cardiovascular disease.
Cough Restriction Individuals with a persistent, chronic cough (such as with asthma or emphysema) or a cough accompanied by excessive phlegm must consult a health professional.

Special Population Status

Pregnancy and Lactation: The use of Piriton-CS is generally not recommended during pregnancy unless considered essential by a physician, and is contraindicated during lactation (breastfeeding) due to the risk of the components passing into breast milk.

What should I know about interactions with other medicines?

Piriton-CS Interactions with other medicines and products

It is essential to inform your healthcare provider or pharmacist about all prescription, over-the-counter (OTC) medicines, vitamins, and herbal products you are currently taking before starting Piriton-CS, as its active ingredients, chlorphenamine and pseudoephedrine, can interact with numerous substances.

  • Monoamine Oxidase Inhibitors (MAOIs): Piriton-CS must not be taken with or within 14 days of stopping MAOIs (a class of antidepressants) due to the risk of severe side effects, including a hypertensive crisis (sudden, severe high blood pressure).

  • Central Nervous System (CNS) Depressants: Concurrent use of Piriton-CS with other medications that cause drowsiness may increase the sedative effect. This includes:

    • Alcohol
    • Other antihistamines (including other cough/cold medicines)
    • Sedatives, tranquilizers, and hypnotics (sleep medicines)
    • Opioid pain relievers
    • Certain medicines for anxiety, depression (like tricyclic antidepressants), or seizures.

  • Other Sympathomimetics: Combining Piriton-CS with other decongestants or stimulant medicines, even those found in other cough, cold, or allergy preparations, should be avoided. This can increase the risk of cardiovascular side effects, such as elevated blood pressure, increased heart rate, and palpitations, due to the pseudoephedrine component.

Category Examples of Potentially Interacting Drugs
Anticholinergic Drugs Medicines for bladder problems, certain anti-spasmodic drugs, or drugs for Parkinson's disease.
Blood Pressure Medicines Drugs for high blood pressure (antihypertensives) may have their effects reduced.

Consult a healthcare professional to determine if an interaction may occur.

Mechanism of Action

Piriton-CS is a dual-component formulation that exerts its effect through two distinct pharmacodynamic pathways. The cetirizine component functions as a highly selective antagonist of peripheral mathbfH1 receptors. By occupying these receptors, it competitively inhibits the binding of endogenous histamine. This molecular interaction prevents the activation of the H1 signaling cascade, thereby inhibiting the downstream physiological consequences, such as increased vascular permeability and localized inflammatory responses initiated by mast cell degranulation. The second component, pseudoephedrine, is a sympathomimetic amine that mediates its action by stimulating mathbfalpha and mathbfbeta adrenergic receptors. This agonistic effect results in vasoconstriction, primarily within the nasal mucosa. The resulting reduction in local vascular bed diameter and blood flow modulates microcirculation, which decreases both vascular permeability and tissue fluid exudation (edema) in the target area. The combined mechanism limits H1-mediated signaling while simultaneously modulating sympathetic activity to control microvascular dynamics.

Dosage and Administration Information

Official Administration and Dosage Guidelines

Piriton-CS, an oral liquid containing Chlorpheniramine Maleate and Dextromethorphan Hydrobromide, is administered strictly via the oral route. The official instructions for use are based on age-specific volume measurements and frequency.

Procedural Instructions

To ensure accurate dosing, the liquid must be measured only with the dosing cup or spoon provided with the product, not with standard household utensils. The medication is generally intended for short-term use, with official guidelines advising against continuous use for more than seven days without consulting a healthcare professional.

Age Group Standard Labeled Dose (Example Concentration) Frequency & Maximum
Adults and Children 12 years and older 20 mL Every 6 hours, not to exceed 4 doses in a 24-hour period.
Children 6 to under 12 years 10 mL Every 6 hours, not to exceed 4 doses in a 24-hour period.
Children under 6 years Do not use Use in this age group is officially not recommended.

These official instructions define the standardized procedure for using Piriton-CS, focusing on mandatory oral administration, precise measurement, and strict adherence to age-based volume limits and frequency constraints.

Recent Clinical Evidence

Recent Clinical Evidence

Mechanism of Action Research

Preclinical research explored the mechanism of action, focusing on the enzyme X. Basic research explored the potential role of X in the progression of Condition A. Preclinical studies evaluated the drug’s selectivity for X over other enzymes. Researchers theorized about the potential link between selectivity and observed side effects.

Clinical Efficacy Studies

Clinical trials enrolled participants with moderate-to-severe disease. Studies evaluated whether the drug was associated with measured changes in symptoms and in the reported frequency of other interventions.

  • Phase 3 Trial Findings: A large-scale Phase 3 trial compared symptom scores reported by the study group and a control group over 52 weeks. Researchers investigated the timing of observed changes in clinical trials.
  • Long-Term Follow-up: Long-term studies also tracked the incidence of flare-ups over time. Early research examined the relationship between the drug and reported scores on pain and quality of life measures.

Pharmacokinetics and Safety

Studies of pharmacokinetics (how the body handles the drug) examined whether taking the medication with food affected absorption. Studies provided data on the drug's half-life and distribution in the body.

  • Side Effect Profile: All clinical trials documented the occurrence and severity of adverse events, including the most frequently reported side effects.
  • Drug-Drug Interactions: Studies explored the possible interactions of the drug with alcohol, including effects on side effect profiles. Researchers also evaluated the potential interactions with other common medications relevant to Condition A.

Frequently Asked Questions (FAQ)

Common questions about Piriton-CS (FAQ)

Q: Do older adults need to use Piriton-CS differently?

Official dosing instructions for adults 12 years and older are consistent. However, according to regulatory documents, older adults may experience increased susceptibility to certain side effects. These can include marked drowsiness, dizziness, confusion, and difficulty with urination. This elevated risk profile is noted in regulatory information.

Q: What are the signs of a serious reaction to Piriton-CS?

Official labeling requires patients to stop use and seek immediate emergency attention if certain severe symptoms occur. These may include a severe headache, a fast or pounding heart rate, severe anxiety, or a seizure. These are considered severe symptoms documented in product information.

Q: Does Piriton-CS contain antihistamines or steroids?

The product contains the active ingredients Chlorpheniramine Maleate, which is an antihistamine, and Dextromethorphan HBr, a cough suppressant. Regulatory product information does not list any steroid compounds in the active or inactive ingredients.

Q: If I have kidney or liver issues, is Piriton-CS safe for me?

Regulatory labeling requires consultation with a doctor or pharmacist prior to use for individuals with pre-existing liver disease or kidney disease. This precaution is noted due to the way the body processes the medication’s active components.

Q: What is the most serious risk associated with Piriton-CS as described in official documents?

The most severe risk detailed in official documents is related to taking the product with, or within 14 days of stopping, a Monoamine Oxidase Inhibitor (MAOI). Regulatory information strictly prohibits this combination because it carries the risk of severe effects, such as a hypertensive crisis (sudden, severe high blood pressure).

Q: Does Piriton-CS affect blood pressure or blood sugar levels?

Official warnings advise caution for individuals with high blood pressure. Regulatory guidance requires individuals with high blood pressure or diabetes to consult a healthcare professional before use. This is because certain components in combination cold medicines may affect blood glucose control.

Q: How long does it usually take to feel the effect of Piriton-CS?

Clinical data on the antihistamine component (Chlorpheniramine) indicates that the medication generally begins to take effect within one to two hours after it is taken. The effects are typically noticeable relatively quickly after administration.

Q: Can I use Piriton-CS if I am taking over-the-counter pain relievers?

Caution is advised. While not an absolute contraindication for all pain relievers, official labeling warns that pain relievers, especially those containing opioids, may increase the sedative effect. Official labeling requires that the components of other products be checked to avoid accidentally combining similar ingredients.

Q: Are there certain foods or drinks to avoid when using Piriton-CS?

Official labels explicitly warn against the consumption of alcoholic beverages while using Piriton-CS, as alcohol can significantly increase the drowsiness caused by the medication. There are typically no specific warnings about non-alcoholic foods or drinks.

Q: Is Piriton-CS addictive or habit-forming?

Official warnings from regulatory bodies exist regarding the potential for the Dextromethorphan component to be misused or abused at doses higher than recommended. This potential for misuse is noted because it increases the risk of developing a substance use disorder.

Q: Are there any known interactions between Piriton-CS and herbal supplements?

Regulatory documents require that a healthcare professional be informed about all prescription, over-the-counter medicines, vitamins, and herbal products currently being taken. This measure is required due to the potential for the active ingredients to interact with various other substances.

Q: Does Piriton-CS work immediately or does it build up in the system?

Studies indicate the active components are absorbed and start working within a couple of hours. Since the antihistamine has a long half-life, the ingredients remain in the body for a significant period after each use.

Q: Can Piriton-CS be used for symptoms caused by pet allergies?

According to the official product information, the product is indicated to temporarily relieve symptoms like runny nose and sneezing due to the common cold and allergic conditions. This includes symptoms caused by both seasonal and perennial (such as pet-related) allergens.

Q: What does 'contraindication' mean in relation to Piriton-CS?

In regulatory documents, a contraindication is defined as a specific circumstance where the product must not be used because the risk of harm clearly outweighs the benefit. Examples include taking an MAOI or using it in a prohibited age group.

Q: Is it common to feel nervous or restless after using Piriton-CS?

Official labels note that a feeling of excitability may occur, particularly in children, instead of the expected drowsiness. Nervousness or restlessness is also listed as a known side effect in product information.

Q: Is Piriton-CS available in different strengths or forms?

The combination of Chlorpheniramine and Dextromethorphan is widely available in different strengths and various forms such as oral liquids, syrups, and tablets. The specific form and strength may vary depending on the brand and regulatory region.

Q: Are there specific instructions for what to do if a side effect occurs?

Regulatory labels define conditions that require the patient to stop use and consult a doctor if certain symptoms occur. This includes if the cough persists for more than one week, or is accompanied by fever, rash, or persistent headache.

Q: What is the regulatory status of Piriton-CS in the USA or UK?

This combination of ingredients is generally classified as an Over-The-Counter (OTC) product in the USA. In the UK, it is often categorized as a Pharmacy Medicine (P), meaning it is available without a prescription but must be sold under the supervision of a pharmacist.

Q: Can Piriton-CS cause changes in mood?

Official adverse event reports for the active ingredients include psychiatric effects. These reports have noted changes in mood such as confusion, excitation, irritability, nightmares, and depression.

Q: Why do doctors prescribe Piriton-CS for conditions other than allergies?

In addition to allergic conditions (like runny nose and sneezing), the product is specifically indicated for the symptomatic relief of cough due to minor throat and bronchial irritation associated with the common cold. This cough suppression is the primary non-allergy function.

Q: How long does Piriton-CS stay in the body after I stop using it?

Both active ingredients have relatively long half-lives, meaning they stay in the body for an extended time. The half-life of Chlorpheniramine ranges from approximately 14 to 43 hours, indicating it can take several days for the drug to be fully eliminated from the body.

How should Piriton-CS be stored and disposed of?

Official Storage and Disposal Conditions for Piriton-CS

The storage and disposal of Piriton-CS (Chlorpheniramine Maleate and Dextromethorphan Hydrobromide Oral Solution) must adhere strictly to the conditions outlined in regulatory labeling to maintain stability and ensure safety.

Storage Condition Category Regulatory Requirement
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F); do not exceed 30 C.
Handling Constraints Do not refrigerate or expose the product to excessive heat or moisture. Keep the container tightly closed and away from sunlight.
Child Safety A mandatory instruction on the label is to keep Piriton-CS out of the reach of children at all times.
Disposal Unused or expired medication must be properly discarded. Do not flush the syrup down the toilet or pour it into a drain; consult a pharmacist or local waste disposal company for appropriate collection procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Piriton-CS found in:

A-Z Index: